1. Home
  2. BFRIW

BFRIW

Biofrontera Inc. Warrants

Logo Biofrontera Inc. Warrants

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 10:32am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.

Founded: N/A Country:
United States
United States
Employees: 85 City: WOBURN
Market Cap: N/A IPO Year: 2021
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: